EPRX: Eupraxia Pharmaceuticals Inc. Kompaniya qiymatining sof foydaga nisbati

Eupraxia Pharmaceuticals Inc. (EPRX) korporativ emblemasi va logotipi

Eupraxia Pharmaceuticals (EPRX) uzoq muddatli ta'sirga ega dori yetkazib berish tizimlarini ishlab chiqishga e'tibor qaratadi, bu esa uning yechimlari noyobligi tufayli yuqori daromadni ta'minlaydi. Biznes analgetiklarga bo'lgan barqaror talabga tayanadi, bu esa iqtisodiy sikllar yoki inflyatsiyadan mustaqil qoladi. Kompaniyaning narxlar grafigi -9.00 qiymatini ko'rsatmoqda, ishlab chiqarish esa qisman avtomatlashtirilgan, garchi klinik aloqalar inson boshqaruvi ostida qolgan bo'lsa-da.

EPRX Eupraxia Pharmaceuticals, Inc.: Narx-foyda koeffitsiyenti 06.04.2024 - 16.11.2026 oraligʻida

Eupraxia Pharmaceuticals, Inc. (EPRX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

Kompaniyaning har tomonlama tahlili:Eupraxia Pharmaceuticals Inc. - EPRX
Eupraxia Pharmaceuticals Inc. yetakchi tovari

Eupraxia Pharmaceuticals osteoartrit og'riqlarini uzoq muddatli boshqarish uchun innovatsion DiffuSphere texnologiyasini ishlab chiqmoqda. P/E koeffitsiyenti sof foydaning bir birligining bozor qiymatini belgilaydi va investorlarning biznesning kelgusidagi o'sishi uchun qo'shimcha to'lov qilishga tayyorligini aks ettiradi. Ushbu metrika aktiv uchun haddan tashqari ko'p to'lash xavfi va imkoniyatlarni boy berish ehtimoli o'rtasidagi muvozanatni ta'minlaydi. Taxminiy P/E koeffitsiyenti dinamikasini tahlil qilish orqali aksiyalar kompaniyaning haqiqiy daromadlariga nisbatan qanchalik qimmat baholanganini aniqlash mumkin.

Muhim raqobatchilar

HLN: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti KVUE (Kenvue Corp)|VRNA (Verona Pharma Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Jyong Biotech Limited MENS|Ligand (LGND) - Kapitalizatsiyaning foydaga nisbati|AMRX: Narx-foyda koeffitsiyenti|Perrigo - Bozor narxining sof foydaga nisbati|ALVO: P/E multiplikatori|Liquidia Technologies - Kompaniya qiymatining sof foydaga nisbati|GLPG (Galapagos N.V.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati anipharmaceuticals.com ANIP|Narxning foydaga nisbati MannKind (MNKD)|AMPH (Amphastar Pharmaceuticals, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Pacira BioSciences, Inc. PCRX|P/E multiplikatori ARS Corp SPRY|Theravance Biopharma - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Aquestive Therapeutics, Inc. (AQST)|scPharmaceuticals (SCPH) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Tectonic Therapeutic, Inc.|TNXP (Tonix Pharmaceuticals Holding) - P/E multiplikatori|Narx-foyda multiplikatori SXTC (China SXT Pharmaceuticals)|P/E multiplikatori BHST|EXOZ - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori ORMP (oramed.com)|P/E multiplikatori enterabio.com ENTX|HYFT - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati ABVC BioPharma, Inc ABVC|CPIX: P/E multiplikatori|Quantum BioPharma Ltd - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti FGEN|Telomir Pharmaceuticals, Inc. - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori RANI|SNYR (Synergy CHC) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Rallybio RLYB|Lexaria Bioscience (LEXX) - Kapitalizatsiyaning foydaga nisbati|PULM - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Pheton Holdings PTHL|APM (Aptorum) - Narx-foyda koeffitsiyenti|Lyra Therapeutics, Inc. (LYRA) - P/E multiplikatori|IBO (impactbiomedinc.com) - P/E multiplikatori|TNFA (TNF Pharmaceuticals) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati cbdmd.com (YCBD)|Biznesning o‘zini qoplash muddati PainReform Ltd|P/E multiplikatori CYTO (Altamira Therapeutics Ltd.)|Lipella Pharmaceuticals (LIPO) - Kapitalizatsiyaning foydaga nisbati|OPTN - Narxning foydaga nisbati|Pieris Pharmaceuticals - Bozor narxining sof foydaga nisbati|PROC (Procaps Group) - Narx-foyda koeffitsiyenti|PTPI - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Qilian International Holding Group Limited|SLRN: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti TFFP (TFF Pharma)